Next Article in Journal
Alkamides in Zanthoxylum Species: Phytochemical Profiles and Local Anesthetic Activities
Previous Article in Journal
Molecules That Have Rarely Been Studied in Lymphatic Endothelial Cells
Previous Article in Special Issue
Advancing Craniopharyngioma Management: A Systematic Review of Current Targeted Therapies and Future Perspectives
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869

1
Canada’s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada
2
Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada
3
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada
4
Pancreas Centre BC, Vancouver, BC V5Z 1G1, Canada
5
Department of Medical Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada
6
Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(22), 12225; https://doi.org/10.3390/ijms252212225
Submission received: 12 October 2024 / Accepted: 16 October 2024 / Published: 14 November 2024
(This article belongs to the Special Issue Precision Medicine in Oncology)
The journal’s Editorial Office and Editorial Board are jointly issuing a resolution and removal of the Journal Notice linked to this article [1]. Following concerns raised about the integrity of the peer-review (misconduct by one of two reviewers), the Editorial Office has conducted a post-publication peer-review of this article. This process included the recruitment of a new independent reviewer and was supervised by the original Academic Editor to ensure full compliance with MDPI’s Editorial Process (https://www.mdpi.com/editorial_process). The authors were unaware of misconduct by the reviewer, and had not included any suggestions by the reviewer for inappropriate references.
As a result of this process, the Academic Editor and the authors have agreed to update the following aspect(s) of this publication:
Reviewer report 2 has been removed from the peer-review record, while one new review report has been added and uploaded to the peer-review record (https://www.mdpi.com/1422-0067/24/6/5869/review_report).
With this update, the Academic Editor is satisfied that the editorial process related to this article has been completed as per MDPI’s Editorial Process policy. The Editorial Office would like to thank the authors for their collaboration during this process.

Reference

  1. Titmuss, E.; Milne, K.; Jones, M.R.; Ng, T.; Topham, J.T.; Brown, S.D.; Schaeffer, D.F.; Kalloger, S.; Wilson, D.; Corbett, R.D.; et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Titmuss, E.; Milne, K.; Jones, M.R.; Ng, T.; Topham, J.T.; Brown, S.D.; Schaeffer, D.F.; Kalloger, S.; Wilson, D.; Corbett, R.D.; et al. Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869. Int. J. Mol. Sci. 2024, 25, 12225. https://doi.org/10.3390/ijms252212225

AMA Style

Titmuss E, Milne K, Jones MR, Ng T, Topham JT, Brown SD, Schaeffer DF, Kalloger S, Wilson D, Corbett RD, et al. Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869. International Journal of Molecular Sciences. 2024; 25(22):12225. https://doi.org/10.3390/ijms252212225

Chicago/Turabian Style

Titmuss, E., K. Milne, M. R. Jones, T. Ng, J. T. Topham, S. D. Brown, D. F. Schaeffer, S. Kalloger, D. Wilson, R. D. Corbett, and et al. 2024. "Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869" International Journal of Molecular Sciences 25, no. 22: 12225. https://doi.org/10.3390/ijms252212225

APA Style

Titmuss, E., Milne, K., Jones, M. R., Ng, T., Topham, J. T., Brown, S. D., Schaeffer, D. F., Kalloger, S., Wilson, D., Corbett, R. D., Williamson, L. M., Mungall, K., Mungall, A. J., Holt, R. A., Nelson, B. H., Jones, S. J. M., Laskin, J., Lim, H. J., & Marra, M. A. (2024). Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869. International Journal of Molecular Sciences, 25(22), 12225. https://doi.org/10.3390/ijms252212225

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop